Why Investors Shouldn't Be Surprised By Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'s (SZSE:002399) Low P/S
You may think that with a price-to-sales (or "P/S") ratio of 2.8x Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SZSE:002399) is a stock worth checking out, seeing as almost half of all the Pharmac
Solid Earnings Reflect Sichuan Biokin PharmaceuticalLtd's (SHSE:688506) Strength As A Business
Sichuan Biokin Pharmaceutical Co.,Ltd.'s (SHSE:688506) strong earnings report was rewarded with a positive stock price move. Our analysis found some more factors that we think are good for shareholde
Earnings Troubles May Signal Larger Issues for Yantai Dongcheng Pharmaceutical GroupLtd (SZSE:002675) Shareholders
The market rallied behind Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s (SZSE:002675) stock, leading do a rise in the share price after its recent weak earnings report. We think that shareholders
Huapont Life SciencesLtd's (SZSE:002004) Conservative Accounting Might Explain Soft Earnings
The market was pleased with the recent earnings report from Huapont Life Sciences Co.,Ltd (SZSE:002004), despite the profit numbers being soft. However, we think the company is showing some signs tha
Harbin Pharmaceutical Group's (SHSE:600664) Anemic Earnings Might Be Worse Than You Think
The market rallied behind Harbin Pharmaceutical Group Co., Ltd.'s (SHSE:600664) stock, leading do a rise in the share price after its recent weak earnings report. We think that shareholders might be
JiangSu WuZhong Pharmaceutical Development (SHSE:600200) Climbs 5.8% This Week, Taking Five-year Gains to 79%
JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHSE:600200) shareholders might be concerned after seeing the share price drop 13% in the last month. But that doesn't change the fact that the